Newsfeed : FDA Staff Supports Truvada PrEP in Advance of Hearing

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » May 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


May 9, 2012

FDA Staff Supports Truvada PrEP in Advance of Hearing

Staff from the Food and Drug Administration (FDA) have found Truvada, a pill from Gilead Sciences, to be safe and effective when used to protect HIV-negative people from getting the virus, Bloomberg Businessweek reports. Gilead would be the first company to sell a drug for pre-exposure prophylaxis (PrEP) treatment. FDA staff found Truvada to be “well-tolerated,” and they accepted data from two studies that supported its ability to reduce the risk of infection. Regulators have said that their main concerns are when and how it should be used, what tests should be required for patients and what information should be used for patients and doctors. FDA advisers will hold a hearing May 10 to consider approving Truvada as PrEP.  

To read the Bloomberg Businessweek article, click here.

Search: Truvada, Bloomberg Businessweek, Gilead, HIV, AIDS, PrEP, medication, treatment

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.